Search for: "Mylan Pharmaceuticals"
Results 601 - 620
of 739
Sorted by Relevance
|
Sort by Date
26 Oct 2007, 1:00 am
Paroxetine - Mylan enters into a patent license and settlement with GlaxoSmithKline (GSK) relating to Paroxetine Hydrochloride (HCl) Extended-release (ER) Tablets (Phillip Brooks), (IP Law360), The perils of not registering copyright in the USA - Seeking only minimal recognition for his Baltimore Ravens logo design, Baltimore amateur artist ends up seeking certiori from the Supreme Court in his copyright infringement case, winds up with no damages award (Maryland IP Law Blog), Amgen's… [read post]
22 Apr 2010, 3:51 am
Teva Pharmaceutical Industries Ltd. et al. [read post]
27 Jun 2011, 8:41 am
Amicus brief of Mylan Pharmaceuticals, Inc. [read post]
10 Oct 2014, 1:16 pm
JHP Pharmaceuticals, LLC v. [read post]
5 Apr 2007, 5:39 am
Von Eschenbach, 459 F.3d 1033, 1043 (10th Cir. 2006); Mylan Pharmaceuticals, Inc. v. [read post]
1 Feb 2013, 9:42 am
Mylan Inc., ___ F. [read post]
21 Feb 2014, 8:53 am
Mylan, Inc., 911 F. [read post]
28 Dec 2010, 10:58 am
Caraco Pharmaceutical Laboratories, Ltd., 601 F.3d 1359 (Fed. [read post]
11 Nov 2009, 4:02 am
: Bilski (IP Frontline) US: Next up: Ariad v Lilly rehearing en banc (Patent Docs) Products Ablify (Aripiprazole) – US: Otsuka files patent infringement suit against Teva in response to Para IV challenge (Patent Docs) Boniva (Ibandronic acid) – US: Roche drops two lawsuits in response to Teva cancelling plans to manufacture generic Boniva (The IP Factor) Copaxone (Glatiramer) – US: Teva files amended complaint against Momenta/Sandoz to include infringement of three… [read post]
16 Mar 2011, 3:50 am
(EFF) US: Inter-agency group takes on counterfeit pharmaceuticals (PatentlyBIOtech) US: Recent Hatch-Waxman scholarship suggests patent settlement and product hopping create a ‘lethal combination’; another article proposes a ‘Smith Barney approach’ to 180-day exclusivity (FDA Law Blog) US: Sen Harkin urges FDA to avoid delays of generic drug approvals (GenericsWeb) Products Actos (Pioglitazone) – US: Takeda files patent infringement complaint against Apotex… [read post]
9 Apr 2009, 7:52 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US CAFC clarifies obviousness standard in context of cDNA cloning invention: In re Kubin (Holman's Biotech IP Blog) (Patent Docs) (Hal Wegner) (Philip Brooks' Patent Infringement Updates) (Patently-O) (Patent Docs) Xigris (Drotrecogin alfa) –US: CAFC: Pioneering claims require more expansive written description: Ariad v Eli… [read post]
22 Jun 2012, 11:29 am
A nice salary, no doubt, but lets compare that to the billions in compensation going to pharmaceutical and other executives. [read post]
13 Nov 2015, 4:54 am
Mylan Inc., 840 F. [read post]
17 Sep 2016, 4:56 am
| Good news and bad news for bio-pharmaceutical patenting in the United States | HP? [read post]
12 Apr 2017, 9:52 am
(collectively, Novartis).The Board instituted IPRs on all claims of the ’283 patentbased on petitions filed by Torrent PharmaceuticalsLimited, Apotex, Inc. and Mylan Pharmaceuticals Inc. [read post]
19 Apr 2022, 2:41 am
Ono: Multiple approved products covered by the same patentThe case in Ono Pharmaceutical v Commissioner of Patents ([2021] FCA 643) related to Ono's PD-1 inhibitor OPDIVO (nivolumab). [read post]
7 Nov 2014, 5:52 am
Teva Pharmaceuticals USA, Inc., 819 F. [read post]
12 Oct 2018, 1:24 pm
Mylan Pharmaceuticals Inc., Nos.17-1594, 17-1595, 17-1596 (Fed. [read post]
5 Apr 2012, 11:54 am
Mylan Pharmaceuticals, Inc., ___ F. [read post]
3 Jul 2022, 6:50 pm
Mylan Pharmaceuticals Inc. 21-1567Issue: Whether 35 U.S.C. [read post]
